CADTH | Homepage

Powering evidence-informed drug and health technology decisions for sustainable, world-class health care for all

We are experts at finding, interpreting, and assembling the best available information, and we know that evidence is the foundation of good decision-making.

National Capital Region's Top Employers 2024 logo

A National Capital Region’s top employer

National Capital Region's Top Employers 2024 logo

We are proud and excited to share that our organization has been named one of the National Capital Region's top employers for 2024.

Latest News

New guidance from an expert panel offers recommendations on minimum retesting intervals for 5 laboratory tests that are commonly repeated in hospitals ...
In mid-March, we identified a cybersecurity incident in which an external party gained access to an application in our IT systems. We discovered the ...
Registration is now open for Symposium 2024, a flagship event in the health technology assessment (HTA) community. Symposium 2024 will be held on ...
Health Canada’s Notice of Compliance with conditions (NOC/c) policy has been effective in providing people in Canada with faster access to new ...
As part of our ongoing initiative to improve and modernize our reimbursement review program, Canada’s Drug Agency is introducing the first phase of ...
Canada’s Drug Agency has published a new report on an economic modelling approach used in evaluations of tumour-agnostic drugs that treat cancer. The ...

Canada’s Drug Agency

Canada’s Drug Agency is a pan-Canadian health organization.

Created and funded by Canada’s federal, provincial, and territorial governments, we’re responsible for driving better coordination, alignment, and public value within Canada’s drug and health technology landscape.

We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact. 

Upcoming Events

HTAi 2024 Annual Meeting

8:00 am

Real-World Evidence Bootcamp

8:00 am

An Update on the Development of Newborn Screening Guidance in Canada 

Thursday, July 11, 2024, 1:00 p.m. to 2:00 p.m. ET   

Canada’s Drug Agency recognizes the traditional territories, rights, and diversity of all First Nations, Inuit, and Métis communities across Canada. Indigenous Peoples have been, and continue to be, excluded from and harmed by Canada’s health care systems. In the spirit of reconciliation, we are committed to addressing these inequities alongside Indigenous communities.